BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7104089)

  • 1. Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.
    Phillips AG; LePiane FG
    Behav Brain Res; 1982 Jun; 5(2):225-9. PubMed ID: 7104089
    [No Abstract]   [Full Text] [Related]  

  • 2. The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus.
    Joyce EM; Koob GF; Strecker R; Iversen SD; Bloom FE
    Brain Res; 1981 Sep; 221(2):359-70. PubMed ID: 7025963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain.
    Glimcher PW; Giovino AA; Margolin DH; Hoebel BG
    Behav Neurosci; 1984 Apr; 98(2):262-8. PubMed ID: 6586195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerability to stressor-induced disturbances in self-stimulation from the dorsal and ventral A10 area: differential effects of intraventricular D-Ala2-Met5-enkephalinamide, D-Ala2, N-Me-Phe4, Gly-Ol5-enkephalin, and D-Pen2, D-Pen5-enkephalin administration.
    Zacharko RM; Maddeaux C; Hebb AL; Mendella PD; Marsh NJ
    Brain Res Bull; 1998 Oct; 47(3):237-48. PubMed ID: 9865856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.
    Broekkamp CL; Phillips AG; Cools AR
    Nature; 1979 Apr; 278(5704):560-2. PubMed ID: 431721
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic terminal excitability: effects of opioids.
    Nakamura S; Tepper JM; Young SJ; Ling N; Groves PM
    Neurosci Lett; 1982 May; 30(1):57-62. PubMed ID: 6124916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the respiratory activity of (D-Ala2)methionine-enkephalinamide.
    Zobrist RH; Allerton HW; Isom GE
    Eur J Pharmacol; 1981 Mar; 70(2):121-8. PubMed ID: 6790294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization.
    Kalivas PW; Taylor S; Miller JS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):537-43. PubMed ID: 2865357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat.
    Kelley AE; Stinus L; Iversen SD
    Behav Brain Res; 1980 Feb; 1(1):3-24. PubMed ID: 6269560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative analysis of the shaking behavior induced in rats by beta-endorphin and [D-Ala2, Met5]enkephalinamide.
    Cowan A; Tortella FC
    Life Sci; 1982 Jan; 30(2):171-6. PubMed ID: 6275233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoaminergic modulation of the analgesia induced in rats by (D-Ala2)-met-enkephalinamide (DADA)].
    Garzón J; Moratalla R; del Río J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):177-9. PubMed ID: 546335
    [No Abstract]   [Full Text] [Related]  

  • 15. Spreading depression induced by microinjection of enkephalins into the hippocampus and neocortex.
    Sprick U; Oitzl MS; Ornstein K; Huston JP
    Brain Res; 1981 Apr; 210(1-2):243-52. PubMed ID: 7225810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (D-Ala2, N-Val5), (D-Ala2, Met5) enkephalins and enkephalinamides. Correlation between biological activity and NMR features.
    Gairin JE; Haran R; Mazarguil H; Audigier Y; Cros J
    FEBS Lett; 1981 Jun; 128(1):51-4. PubMed ID: 6268450
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of D-alanine methionine enkephalin amide on ion transport in rabbit ileum.
    Dobbins J; Racusen L; Binder HJ
    J Clin Invest; 1980 Jul; 66(1):19-28. PubMed ID: 6249844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of taurine and gamma-aminobutyric acid on akinesia and analgesia induced by D-Ala2-Met-enkephalinamide in rats.
    Izumi K; Munekata E; Yamamoto H; Nakanishi T; Barbeau A
    Peptides; 1980; 1(2):139-46. PubMed ID: 7243612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central neuropharmacology of D-Ala2-Met-enkephalinamide and its interactions with taurine in rats.
    Izumi K; Munekata E; Yamamoto H; Yoshida M; Nakanishi T; Wong P; Barbeau A
    Adv Exp Med Biol; 1981; 139():325-43. PubMed ID: 7199249
    [No Abstract]   [Full Text] [Related]  

  • 20. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.
    Kalivas PW; Abhold R
    Brain Res; 1987 Jun; 414(2):339-48. PubMed ID: 3620936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.